Hyperfine, Inc.

NasdaqGM HYPR

Hyperfine, Inc. Price to Book Ratio (P/B) on February 06, 2025

Hyperfine, Inc. Price to Book Ratio (P/B) is NA on February 06, 2025, a NA change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Hyperfine, Inc. 52-week high Price to Book Ratio (P/B) is NA on February 06, 2025, which is NA below the current Price to Book Ratio (P/B).
  • Hyperfine, Inc. 52-week low Price to Book Ratio (P/B) is NA on February 06, 2025, which is NA below the current Price to Book Ratio (P/B).
  • Hyperfine, Inc. average Price to Book Ratio (P/B) for the last 52 weeks is NA.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
SV Wall Street
NasdaqGM: HYPR

Hyperfine, Inc.

CEO Ms. Maria Sainz
IPO Date Jan. 28, 2021
Location United States
Headquarters 351 New Whitfield Street
Employees 131
Sector Health Care
Industries
Description

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Similar companies

SRDX

Surmodics, Inc.

USD 34.06

0.62%

LIVN

LivaNova PLC

USD 49.95

-1.36%

IRMD

IRadimed Corporation

USD 61.36

-2.09%

ELMD

Electromed, Inc.

USD 34.30

-2.22%

APYX

Apyx Medical Corporation

USD 1.39

-6.08%

ITGR

Integer Holdings Corporation

USD 140.91

-1.01%

KIDS

OrthoPediatrics Corp.

USD 23.71

-3.85%

LUNG

Pulmonx Corporation

USD 6.43

4.55%

INGN

Inogen, Inc.

USD 10.84

-8.52%

OFIX

Orthofix Medical Inc.

USD 18.47

-2.99%

ANIK

Anika Therapeutics, Inc.

USD 17.79

-1.00%

NPCE

NeuroPace, Inc.

USD 13.66

-4.41%

StockViz Staff

February 7, 2025

Any question? Send us an email